Neurólogos y asociaciones piden financiación pública para fármacos que ralentizan el Alzheimer

On World Alzheimer's Day, the Spanish Confederation of Alzheimer's Associations (CEAFA) and the Spanish Society of Neurology are protesting the government's refusal to fund two new drugs that slow cognitive decline. While approved in the US, UK, Japan, and China, these treatments remain accessible only via private healthcare in Spain, leaving many patients abandoned.